Investment Firm
Overview
CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.
Oct 22, 2020
Series Unknown
Highlights
Location
Social
Participant Investors
1
Investor Name |
---|
Morningside Venture Investments |
CellCentric raised $33000000 on 2020-10-22 in Venture Round
CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.
Company Funding History
18
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Jul 11, 2023 | Corporate Round - CellCentric | 1 | - | 25.0M |
Jul 24, 2024 | Venture Round - CellCentric | 1 | - | 35.0M |
Jun 01, 2017 | Venture Round - CellCentric | 1 | - | undefined |
Jun 25, 2013 | Venture Round - CellCentric | 4 | - | 6.6M |
Recent Activity
There is no recent news or activity for this profile.